Skip to content

Clinical trials

Communicable Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Communicable Diseases Country / region: China Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20082
20091
20171
20181
20192
20206
20216
20223
20232
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Unknown status8
Recruiting2
Active, not recruiting1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University Third Hospital3
Centers for Disease Control and Prevention2
Changhai Hospital2
Children's Hospital of Fudan University2
Shandong University2
Shenzhen People's Hospital2
Zhejiang University2
AstraZeneca1
AusperBio Therapeutics Inc.1
Beijing Haidian Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Communicable Diseases30
Cardiovascular Diseases2
Cross Infection2
Digestive System Diseases2
Gastrointestinal Diseases2
Neoplasms2
Pancreatic Neoplasms2
Virus Diseases2
Blood-Borne Infections1
COVID-191

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.